Research Articles | Page 93 | Aplastic Anemia & MDS International Foundation Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodyspla Feb 2015 Leukemia myelodysplastic syndromes (MDS)
TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups. Jan 2019 Leukemia myelodysplastic syndromes (MDS)
Deciphering treatment patterns in non-severe/moderate aplastic anemia: an international observational study Oct 2023 Leukemia aplastic anemia
Comparison of clinical outcomes and prognostic utility of risk stratification tools in patients with therapy-related vs de novo myelodysplastic syndromes: a report on behalf of the MDS Clinical Research Consortium. Feb 2017 Leukemia myelodysplastic syndromes (MDS)
Incorporation of molecular data into the Revised International Prognostic Scoring System in treated patients with myelodysplastic syndromes Nov 2016 Leukemia myelodysplastic syndromes (MDS)
Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes Mar 2015 Leukemia myelodysplastic syndromes (MDS)
Effectiveness of azacitidine for the treatment of higher-risk myelodysplastic syndromes in daily practice: results from the Dutch population-based PHAROS MDS registry Sep 2015 Leukemia myelodysplastic syndromes (MDS)
Hypomethylating agents in combination with immune checkpoint inhibitors in acute myeloid leukemia and myelodysplastic syndromes Feb 2018 Leukemia myelodysplastic syndromes (MDS)
Application of the International Prognostic Scoring System-Revised (IPSS-R) in Therapy-related Myelodysplastic Syndromes and Oligoblastic Acute Myeloid Leukemia. Jun 2013 Leukemia myelodysplastic syndromes (MDS)
A phase 3 randomized placebo-controlled trial of darbepoetin alfa in patients with anemia and lower-risk myelodysplastic syndromes Jun 2017 Leukemia myelodysplastic syndromes (MDS)
Share with addtoany.com.